Protocol for a systematic review and economic evaluation of the clinical and cost-effectiveness of non-hospital-based non-invasive ventilation (NIV) in patients with stable end-stage COPD with hypercapnic respiratory failure

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Dave, Chirag ^a   Turner, Alice ^a,b   Dretzke, Janine ^b   Bayliss, Sue ^b   O'Brien, Deirdre ^b   Jowett, Sue ^b   Moore, David ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Clinical effectiveness; COPD; Cost effectiveness; Hypercapnia; Meta analysis; Non hospital based non invasive ventilation; Systematic review

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DATA EXTRACTION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; HYPERCAPNIC RESPIRATORY FAILURE; META ANALYSIS (TOPIC); NONINVASIVE VENTILATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY FAILURE; SURVIVAL; SYSTEMATIC REVIEW; AMBULATORY CARE; COST BENEFIT ANALYSIS; ECONOMICS; HYPERCAPNIA; METHODOLOGY; REVIEW; TREATMENT OUTCOME;

AMBULATORY CARE; COST-BENEFIT ANALYSIS; HUMANS; HYPERCAPNIA; NONINVASIVE VENTILATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84907265251     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-32     Document Type: Article

References (29)

1. National Institute for Clinical Excellence (NICE) CG101 Chronic obstructive pulmonary disease (update): NICE guideline, Access date: 16 Oct. 12 A.D., URL: [http://guidance.nice.org.uk/CG101/NICEGuidance/pdf/English], National Institute for Clinical Excellence (NICE).
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997, 349:1498-1504. 10.1016/S0140-6736(96)07492-2, 9167458.
3. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA, Make B, Rochester CL, Zuwallack R, Herrerias C. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 2007, 131(5 Suppl):4S-42S.
4. Costello R, Deegan P, Fitzpatrick M, McNicholas WT. Reversible hypercapnia in chronic obstructive pulmonary disease: a distinct pattern of respiratory failure with a favorable prognosis. Am J Med 1997, 102:239-244. 10.1016/S0002-9343(97)00017-X, 9217591.
5. Trueman J, Trueman I. COPD: criteria to assist in the identification of the palliative phase. Br J Nurs 2011, 20:635-639.
6. Pierson DJ. History and epidemiology of noninvasive ventilation in the acute-care setting. Respir Care 2009, 54:40-52.
7. Non-invasive ventilation in chronic obstructive pulmonary disorder: management of acute type 2 respiratory failure; RCP/BTS Concise guideline, October 2008, [http://www.rcplondon.ac.uk/resources/concise-guidelines-non-invasive-ventilation-chronic-obstructive-pulmonary-disease].
8. Timothy J, Barreiro DO, Gemmel DJ. Non-invasive ventilation. Crit Care Clin 2007, 23:201-222. 10.1016/j.ccc.2006.11.015, 17368166.
9. Diaz O, Begin P, Andresen M, Prieto ME, Castillo C, Jorquera J, Lisboa C. Physiological and clinical effects of diurnal noninvasive ventilation in hypercapnic COPD. Eur Respir J 2005, 26:1016-1023. 10.1183/09031936.05.00033905, 16319330.
10. Tuggey JM, Plant PK, Elliott MW. Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis. Thorax 2003, 58:867-871. 10.1136/thorax.58.10.867, 1746494, 14514940.
11. Struik FM, Lacasse Y, Goldstein R, Kerstjens HM, Wijkstra PJ. Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013, 6:CD002878.
12. Clini EM, Magni G, Crisafulli E, Viaggi S, Ambrosino N. Home non-invasive mechanical ventilation and long-term oxygen therapy in stable hypercapnic chronic obstructive pulmonary disease patients: comparison of costs. Respiration 2009, 77:44-50. 10.1159/000127410, 18417954.
13. Ottawa Hospital Research Institute. PRISMA Transparent reporting of systematic reviews and meta-analyses, Access date: 17 Oct. 12 A.D., URL: [http://www.prisma-statement.org/], Ottawa Hospital Research Institute. PRISMA.
14. Plant PK, Owen JL, Elliott MW. Early use of non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease on general respiratory wards: a multicentre randomised controlled trial. Lancet 2000, 355:1931-1935. 10.1016/S0140-6736(00)02323-0, 10859037.
15. Shea BJ, Bouter LM, Peterson J, Boers M, Andersson N, Ortiz Z, Ramsay T, Bai A, Shukla VK, Grimshaw JM. External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One 2007, 2:e1350. 10.1371/journal.pone.0001350, 2131785, 18159233.
16. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 Access date: 17 Oct. 12 A.D., URL: [www.cochrane-handbook.org].
17. Higgins JPT, Deeks JJ, Altman D, Gobot CSMG. Chapter 16: Special topics in statistics Access date: 23 Oct. 12 A.D., URL: [http://www.cochrane-handbook.org/].
18. Reeves BC, Deeks JJ, Higgins JPT, Wells GA,. on behalf of the Cochrane Non-Randomised Studies Methods Group Cochrane handbook for systematic reviews of interventions version 5.1.0. Chapter 13: Including non-randomized studies Access date: 17 Oct. 12 A.D., URL: [http://www.cochrane-handbook.org/], on behalf of the Cochrane Non-Randomised Studies Methods Group.
19. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 1998, 52:377-384. 10.1136/jech.52.6.377, 1756728, 9764259.
20. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Access date: 17 Oct. 12 A.D., URL: [http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp].
21. The GRADE working group Grading of recommendations assessment, development and evaluation(GRADE) Access date: 23 Oct. 12 A.D., URL: [http://www.gradeworkinggroup.org/], The GRADE working group.
22. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 1998, 17:2815-2834. 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8, 9921604.
23. The Cochrane Collaboration Chapter 9 Cochrane handbook for systematic reviews of interventions version 5.1.0 (updated March 2011). Analysing data and undertaking meta-analyses 2011, [http://www.cohrane-handbook.org], The Cochrane Collaboration.
24. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis 2009, Chichester: Wiley & Sons Ltd.
25. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006, 295:676-680. 10.1001/jama.295.6.676, 16467236.
26. Donegan S, Williamson P, Gamble C, Tudur-Smith C. Indirect comparisons: a review of reporting and methodological quality. PLoS One 2010, 5:e11054. 10.1371/journal.pone.0011054, 2978085, 21085712.
27. Drummond MF, Sculpher M, Torrance GW, O'Brien B, Stoddart DL. Methods for the economic evaluation of health care programmes. Third edition 2005, Oxford: Oxford University Press.
28. Philips Z, Bojke L, Sculpher M, Claxton K, Golder S. Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 2006, 24:355-371. 10.2165/00019053-200624040-00006, 16605282.
29. Starkie HJ, Briggs AH, Chambers MG, Jones P. Predicting EQ-5D values using the SGRQ. Value Health 2011, 14:354-360. 10.1016/j.jval.2010.09.011, 21402304.